期刊文献+

血清25羟维生素D与老年体位性低血压的相关性分析 被引量:2

Relationship between postural hypotension and serum 25 Hydroxy vitamin D in elderly patients
下载PDF
导出
摘要 目的:探讨老年体位性低血压患者与血清25羟维生素D的关系。方法:回顾性分析546例合格患者的临床特点、血压、共患疾病、多重用药、认知功能和营养状态、基本和功能性的日常生活活动指数及一些实验室检测数据。采用放射免疫分析法检测血清25羟维生素D,并分析血清25羟维生素D与老年体位性低血压的相关性。结果:本研究体位性低血压在老年患者中发病率约27.5%,通过Logistic回归分析,在非校准模型中,25羟维生素D与体位性性低血压发生密切相关(OR=0.24;95%CI=0.12-0.73;P=0.004),而BADL、IADL也有相关性,P值均<0.05。结论:血清25羟维生素D缺乏,可能是老年体位性低血压发生发展的重要因素。 Objective:To investigate the relationship between serum 25 hydroxy vitamin D and elderly patients with orthostatic hypotension. Methods : Retrospective analysis of 546 cases of qualified researchers, clinical features, blood pressure, comorbid diseases, polypharmaey, cognitive function and nutritional status, basic functions and of the index of activities of daily living and laboratory test data. Results : We statistics of orthostatic hypotension incidence rate in elderly patients is 27.5% , by Logistic regression analysis, the non calibration model, 25 hydroxy vitamin D is closely related with orthostatic hypotension (OR =0.24, 95% CI = 0. 12-0. 73, P =0. 004), while IADL and BADL are also related, P value is 〈 0. 05. Conclusion: Lack of serum 25 hydroxy vitamin D, may be an important factor in the development of elderly orthostatie hypotension.
出处 《心肺血管病杂志》 2017年第5期349-352,共4页 Journal of Cardiovascular and Pulmonary Diseases
关键词 25羟维生素D 老年 体位性低血压 相关性 25 hydroxy vitamin D Elderly patients Orthostatic hypotension Correlation
  • 相关文献

参考文献1

二级参考文献16

  • 1Expert Dyslipidemia Panel of the International Atherosclerosis So- ciety. An international atherosclerosis society position paper: Global recommendations for the management of dyslipidemia-full report. J Clin Lipidol, 2014, 8: 29-60.
  • 2Bays HE, Jones PH, Brown VW, et al. National lipid associa- tion annual summary of clinical lipidology 2015. J Clin Lipidol, 2014, 8 : S1-$36.
  • 3Reiner Z, Catapano AL, De Backer G, et al. ESC/EAS guide- lines for the management of dyslipidaemias. Eur Heart J, 2011, 32: 1769-1818.
  • 4Ridker PM. LDL cholesterol : controversies and future therapeutic directions. Lancet, 2014, 384: 607-17.
  • 5Ruiz-Canela M, Toledo E, Clish CB, et al. Plasma branched- chain amino acids and incident cardiovascular disease in the pre- dimed trial. Clin Chem, 2016, 62: 582-592.
  • 6Nestel P, Clifton P, Colquhoun D, et al. Indications for omega-3 long chain polyunsaturated fatty acid in the prevention and treat- ment of cardiovascular disease. Heart Lung Circ, 2015, 24: 769 -779.
  • 7Cahill LE, Bertoia ML, Aroner SA, et al. New and emerging bi- omarkers in cardiovascular disease. Curr Diab Rep, 2015, 15: 88-102.
  • 8Liu WC, Wu CC, Hung YM, et al. Pleiotropic effects of vitamin D in chronic kidney diseas. Clin Chim Acta, 2016, 453: 1-12.
  • 9Wang SM, Wang S, Yang RY, et al. A simple and precise LC- MS/MS method for simultaneous determination of serum 25- hydroxyvitamin D3 and D2 without interference from the Ca epi- mer. Anal Methods, 2015, 7 : 5254-5261.
  • 10Su ZL, Narla SN, Zhu YS. 25-Hydroxyvitamin D: Analysis and clinical application. Clin Chim Acta, 2014, 433: 200-205.

共引文献20

同被引文献13

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部